Human KRT14(Keratin 14) ELISA Kit
 ELISA Kit) Human Keratin 14 (KRT14) ELISA Kit |
|
20-abx152107 |
Abbexa |
-
EUR 7970.40
-
EUR 4250.40
-
EUR 990.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Keratin 14 (KRT14) ELISA Kit |
|
SEA522Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5128.02 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
Human Keratin 14 (KRT14) ELISA Kit |
|
SEA522Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 527.48 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
Human Keratin 14 (KRT14) ELISA Kit |
|
SEA522Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 702.12 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
Human Keratin 14 (KRT14) ELISA Kit |
|
SEA522Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2799.54 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 14 (KRT14) in serum, plasma, tissue homogenates and other biological fluids. |
Human Keratin 14 (KRT14) ELISA Kit |
|
4-SEA522Hu |
Cloud-Clone |
-
EUR 5188.80
-
EUR 2739.60
-
EUR 703.20
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 14 (KRT14) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
) Human Keratin 14 ELISA Kit (KRT14) |
|
RK01739 |
Abclonal |
96 Tests |
EUR 625.2 |
 Antibody) Keratin 14 (KRT14) Antibody |
|
abx146144-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx007358 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 376.80
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx002877 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx109314 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx130248 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx128714 |
Abbexa |
-
EUR 360.00
-
EUR 159.60
-
EUR 910.80
-
EUR 477.60
-
EUR 309.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx113336 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx129637 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx326445 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx327450 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx173244 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx241010 |
Abbexa |
|
|
|
|
Keratin 14 (KRT14) Antibody |
|
20-abx241011 |
Abbexa |
|
|
|
|
) Recombinant Keratin 14 (KRT14) |
|
4-RPA522Hu01 |
Cloud-Clone |
-
EUR 569.44
-
EUR 276.00
-
EUR 1805.38
-
EUR 681.79
-
EUR 1243.58
-
EUR 456.00
-
EUR 4333.44
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Keratin 14 expressed in: E.coli |
Recombinant Keratin 14 (KRT14) |
|
4-RPA522Mu01 |
Cloud-Clone |
-
EUR 593.09
-
EUR 282.00
-
EUR 1894.08
-
EUR 711.36
-
EUR 1302.72
-
EUR 472.80
-
EUR 4555.20
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Mouse Keratin 14 expressed in: E.coli |
Recombinant Keratin 14 (KRT14) |
|
4-RPA522Ra01 |
Cloud-Clone |
-
EUR 625.34
-
EUR 290.40
-
EUR 2015.04
-
EUR 751.68
-
EUR 1383.36
-
EUR 494.40
-
EUR 4857.60
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Keratin 14 expressed in: E.coli |
) ELISA kit for Human KRT14 (Keratin 14) |
|
ELK3888 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Keratin 14 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
 CLIA Kit) Human Keratin 14 (KRT14) CLIA Kit |
|
20-abx491574 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 Protein) Human Keratin 14 (KRT14) Protein |
|
20-abx166632 |
Abbexa |
-
EUR 794.40
-
EUR 326.40
-
EUR 2431.20
-
EUR 944.40
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Rat Keratin 14 (KRT14) Protein |
|
20-abx167739 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2715.60
-
EUR 1045.20
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Mouse Keratin 14 (KRT14) Protein |
|
20-abx168376 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2548.80
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Keratin 14 (KRT14) Antibody (Biotin) |
|
20-abx105606 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Keratin 14 (KRT14) Antibody (HRP) |
|
20-abx108445 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Keratin 14 (KRT14) Antibody (FITC) |
|
20-abx107024 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Keratin 14 (KRT14) Antibody (FITC) |
|
abx415614-01mg |
Abbexa |
0.1 mg |
EUR 610.8 |
|
|
 Human Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|
ELI-37134h |
Lifescience Market |
96 Tests |
EUR 988.8 |
) Human Keratin, type I cytoskeletal 14 (KRT14) |
|
1-CSB-EP012512HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human Keratin, type I cytoskeletal 14(KRT14) expressed in E.coli |
) Human KeRatin, type I cytoskeletal 14 (KRT14) |
|
1-CSB-YP012512HU |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Human KeRatin, type I cytoskeletal 14(KRT14) expressed in Yeast |
 Polyclonal Antibody (Human, Rat)) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat) |
|
4-PAA522Hu01 |
Cloud-Clone |
-
EUR 278.40
-
EUR 2742.00
-
EUR 688.80
-
EUR 346.80
-
EUR 249.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14) |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat) |
|
4-PAA522Ra01 |
Cloud-Clone |
-
EUR 291.60
-
EUR 2948.40
-
EUR 735.60
-
EUR 366.00
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14) |
 Chicken Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|
ELI-12809c |
Lifescience Market |
96 Tests |
EUR 1113.6 |
 Bovine Keratin, type I cytoskeletal 14, KRT14 ELISA KIT |
|
ELI-13309b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
 Mouse Keratin, type I cytoskeletal 14, Krt14 ELISA KIT |
|
ELI-13310m |
Lifescience Market |
96 Tests |
EUR 1038 |
) ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|
KTE61884-48T |
Abbkine |
48T |
EUR 398.4 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|
KTE61884-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Keratin, type I cytoskeletal 14 (KRT14) |
|
KTE61884-96T |
Abbkine |
96T |
EUR 646.8 |
|
|
|
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 14 (KRT14) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
 Polyclonal Antibody (Human, Rat), APC) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC |
|
4-PAA522Hu01-APC |
Cloud-Clone |
-
EUR 387.60
-
EUR 3562.80
-
EUR 1003.20
-
EUR 490.80
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC. |
 Polyclonal Antibody (Human, Rat), Biotinylated) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Biotinylated |
|
4-PAA522Hu01-Biotin |
Cloud-Clone |
-
EUR 354.00
-
EUR 2682.00
-
EUR 805.20
-
EUR 429.60
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Human, Rat), Cy3) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Cy3 |
|
4-PAA522Hu01-Cy3 |
Cloud-Clone |
-
EUR 468.00
-
EUR 4700.40
-
EUR 1287.60
-
EUR 604.80
-
EUR 286.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Human, Rat), FITC) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), FITC |
|
4-PAA522Hu01-FITC |
Cloud-Clone |
-
EUR 334.80
-
EUR 2874.00
-
EUR 825.60
-
EUR 416.40
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with FITC. |
 Polyclonal Antibody (Human, Rat), HRP) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), HRP |
|
4-PAA522Hu01-HRP |
Cloud-Clone |
-
EUR 356.40
-
EUR 3106.80
-
EUR 889.20
-
EUR 445.20
-
EUR 238.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with HRP. |
 Polyclonal Antibody (Human, Rat), PE) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), PE |
|
4-PAA522Hu01-PE |
Cloud-Clone |
-
EUR 334.80
-
EUR 2874.00
-
EUR 825.60
-
EUR 416.40
-
EUR 225.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with PE. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC |
|
4-PAA522Ra01-APC |
Cloud-Clone |
-
EUR 408.00
-
EUR 3843.60
-
EUR 1072.80
-
EUR 518.40
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Biotinylated |
|
4-PAA522Ra01-Biotin |
Cloud-Clone |
-
EUR 368.40
-
EUR 2888.40
-
EUR 856.80
-
EUR 450.00
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Biotin. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), Cy3 |
|
4-PAA522Ra01-Cy3 |
Cloud-Clone |
-
EUR 493.20
-
EUR 5074.80
-
EUR 1381.20
-
EUR 642.00
-
EUR 297.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with Cy3. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), FITC |
|
4-PAA522Ra01-FITC |
Cloud-Clone |
-
EUR 350.40
-
EUR 3098.40
-
EUR 882.00
-
EUR 439.20
-
EUR 232.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with FITC. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), HRP |
|
4-PAA522Ra01-HRP |
Cloud-Clone |
-
EUR 373.20
-
EUR 3350.40
-
EUR 949.20
-
EUR 469.20
-
EUR 246.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with HRP. |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), PE |
|
4-PAA522Ra01-PE |
Cloud-Clone |
-
EUR 350.40
-
EUR 3098.40
-
EUR 882.00
-
EUR 439.20
-
EUR 232.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with PE. |
 Polyclonal Antibody (Human, Rat), APC-Cy7) Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|
4-PAA522Hu01-APC-Cy7 |
Cloud-Clone |
-
EUR 632.40
-
EUR 6981.60
-
EUR 1862.40
-
EUR 837.60
-
EUR 361.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
 Polyclonal Antibody (Human, Mouse, Guinea pig)) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig) |
|
4-PAA522Mu01 |
Cloud-Clone |
-
EUR 283.20
-
EUR 2805.60
-
EUR 703.20
-
EUR 352.80
-
EUR 250.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14) |
Keratin 14 (KRT14) Polyclonal Antibody (Human, Rat), APC-Cy7 |
|
4-PAA522Ra01-APC-Cy7 |
Cloud-Clone |
-
EUR 672.00
-
EUR 7543.20
-
EUR 2002.80
-
EUR 894.00
-
EUR 378.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Rat Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), APC) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), APC |
|
4-PAA522Mu01-APC |
Cloud-Clone |
-
EUR 394.80
-
EUR 3649.20
-
EUR 1024.80
-
EUR 499.20
-
EUR 254.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with APC. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), Biotinylated) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), Biotinylated |
|
4-PAA522Mu01-Biotin |
Cloud-Clone |
-
EUR 358.80
-
EUR 2745.60
-
EUR 820.80
-
EUR 435.60
-
EUR 256.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with Biotin. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), Cy3) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), Cy3 |
|
4-PAA522Mu01-Cy3 |
Cloud-Clone |
-
EUR 476.40
-
EUR 4815.60
-
EUR 1316.40
-
EUR 615.60
-
EUR 289.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with Cy3. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), FITC) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), FITC |
|
4-PAA522Mu01-FITC |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with FITC. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), HRP) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), HRP |
|
4-PAA522Mu01-HRP |
Cloud-Clone |
-
EUR 362.40
-
EUR 3182.40
-
EUR 907.20
-
EUR 452.40
-
EUR 240.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with HRP. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), PE) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), PE |
|
4-PAA522Mu01-PE |
Cloud-Clone |
-
EUR 339.60
-
EUR 2942.40
-
EUR 843.60
-
EUR 423.60
-
EUR 226.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with PE. |
 Polyclonal Antibody (Human, Mouse, Guinea pig), APC-Cy7) Keratin 14 (KRT14) Polyclonal Antibody (Human, Mouse, Guinea pig), APC-Cy7 |
|
4-PAA522Mu01-APC-Cy7 |
Cloud-Clone |
-
EUR 645.60
-
EUR 7154.40
-
EUR 1905.60
-
EUR 855.60
-
EUR 364.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse, Guinea pig Keratin 14 (KRT14). This antibody is labeled with APC-Cy7. |
 Keratin 14 Cell ELISA Kit |
|
abx595639-96tests |
Abbexa |
96 tests |
EUR 764.4 |
|
|
 KRT14 Cytokeratin 14 Human Recombinant Protein |
|
PROTP02533 |
BosterBio |
Regular: 20ug |
EUR 380.4 |
|
Description: Cytokeratin 14 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain having a molecular mass of 51,530 Dalton. ;The KRT14 is purified by proprietary chromatographic techniques. |
 Anti-Cytokeratin 14/KRT14 Antibody |
|
A01432 |
BosterBio |
100ug/vial |
EUR 400.8 |
 polyclonal antibody) Cytokeratin 14 (KRT14) polyclonal antibody |
|
ABP-PAB-11625 |
Allele Biotech |
100 ug |
Ask for price |
|
|
 Rabbit mAb) Cytokeratin 14 (KRT14) Rabbit mAb |
|
A19039 |
Abclonal |
20 μL |
EUR 18 |
 Antibody) Cytokeratin 14(KRT14/532) Antibody |
|
BNC040532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC040532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC050532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC050532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCAP0532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCAP0532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCB0532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCB0532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCP0532-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), PerCP conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCR0532-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), RPE conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC940532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC940532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCA0532-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), APC conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC810532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC810532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNUB0532-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Concentration: 0.2mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNUB0532-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Concentration: 0.2mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCH0532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNCH0532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC880532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC880532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC680532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC680532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC470532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC470532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC400532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC400532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC430532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC430532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC550532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC550532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC610532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC610532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC800532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC800532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC700532-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNC700532-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14(KRT14/532) Antibody |
|
BNUM0532-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Cytokeratin 14(KRT14/532), 1mg/mL |
) Cytokeratin 14 Antibody (CK14, KRT14) |
|
R32606 |
NSJ Bioreagents |
100 ug |
EUR 419 |
 Cytokeratin 14 Antibody / CK14 / KRT14 |
|
RQ4995 |
NSJ Bioreagents |
100ul |
EUR 419 |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
RQ5076 |
NSJ Bioreagents |
100ul |
EUR 419 |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9058-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9058-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9058IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9058SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2668-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2668-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2668IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2668SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7121-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7121-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7121IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7121SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2175-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2175-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2175BTN |
NSJ Bioreagents |
500 ul |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2175IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V2175SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). Cytokeratin 14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. antibody to cytokeratin 14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. cytokeratin 14 antibody is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Cytokeratin 14 antibody is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7917-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7917-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V7917SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9313-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9313-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9313SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9315-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9315-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9315SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9319-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9319-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9319SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. It is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9407-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9407-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
Cytokeratin 14 Antibody / CK14 / KRT14 |
|
V9407SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: Cytokeratin 14 (CK14, KRT14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). KRT14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. |
 Keratin 14 antibody |
|
70R-31248 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal Keratin 14 antibody |
 (Squamous Cell Marker) (KRT14/284) Antibody) Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC040284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC040284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405S conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC050284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC050284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF405M conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCAP0284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCAP0284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCB0284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCB0284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Biotin conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCP0284-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), PerCP conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCR0284-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), RPE conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC940284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC940284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF594 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCA0284-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), APC conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC810284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC810284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNUB0284-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Concentration: 0.2mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNUB0284-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Concentration: 0.2mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCH0284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNCH0284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC880284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC880284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF488A conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC680284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC680284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF568 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC470284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC470284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF647 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC430284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC430284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF543 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC610284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC610284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF660R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC800284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC800284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF680 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC400284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC400284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF640R conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC550284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC550284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF555 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC700284-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNC700284-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), CF770 conjugate, Concentration: 0.1mg/mL |
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/284) Antibody |
|
BNUM0284-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against Cytokeratin 14 (KRT14) (Squamous Cell Marker) ( KRT14/284), 1mg/mL |
) Heart Lysate (14 Days Old) |
|
1401-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Heart tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Lung Lysate (14 Days Old) |
|
1402-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Lung tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Brain Lysate (14 Days Old) |
|
1403-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Brain tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Liver Lysate (14 Days Old) |
|
1404-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Liver tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Kidney Lysate (14 Days Old) |
|
1405-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Kidney tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Spleen Lysate (14 Days Old) |
|
1406-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Spleen tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Thymus Lysate (14 Days Old) |
|
1409-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Thymus tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Stomach Lysate (14 Day Old) |
|
1415-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Stomach tissue lysate (14 Day Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Skin Lysate (14 Days Old) |
|
1419-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Skin tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
) Eye Lysate (14 Days Old) |
|
1420-14 |
ProSci |
0.1 mg |
EUR 229.2 |
|
Description: Eye tissue lysate (14 Days Old) was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
 Polyclonal KRT14 / CK14 / Cytokeratin 14 Antibody |
|
APR03031G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human KRT14 / CK14 / Cytokeratin 14 . This antibody is tested and proven to work in the following applications: |
 Keratin 14 Blocking Peptide |
|
AF5225-BP |
Affbiotech |
1mg |
EUR 234 |
Keratin 14 Blocking Peptide |
|
AF5370-BP |
Affbiotech |
1mg |
EUR 234 |
Keratin 14 Blocking Peptide |
|
AF0736-BP |
Affbiotech |
1mg |
EUR 234 |
 Keratin 14 Colorimetric Cell-Based ELISA |
|
EKC1610 |
BosterBio |
100ul |
EUR 686.4 |
 (OKAN05824)) KRT14 ELISA Kit (Human) (OKAN05824) |
|
OKAN05824 |
Aviva Systems Biology |
96 Wells |
EUR 950.4 |
|
Description: Description of target: This gene encodes a member of the keratin family, the most diverse group of intermediate filaments. This gene product, a type I keratin, is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. At least one pseudogene has been identified at 17p12-p11.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.059 ng/mL |
 (OKDD00362)) KRT14 ELISA Kit (Human) (OKDD00362) |
|
OKDD00362 |
Aviva Systems Biology |
96 Wells |
EUR 1059.6 |
|
Description: Description of target: This gene encodes a member of the keratin family, the most diverse group of intermediate filaments. This gene product, a type I keratin, is usually found as a heterotetramer with two keratin 5 molecules, a type II keratin. Together they form the cytoskeleton of epithelial cells. Mutations in the genes for these keratins are associated with epidermolysis bullosa simplex. At least one pseudogene has been identified at 17p12-p11.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.053 ng/mL |
 (OKCD00245)) KRT14 ELISA Kit (Human) (OKCD00245) |
|
OKCD00245 |
Aviva Systems Biology |
96 Wells |
EUR 950.4 |
|
Description: Description of target: The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro.1 Publication
<p>Manually curated information for which there is published experimental evidence.</p>
<p><a href="/manual/evidences#ECO:0000269">More…</a></p> Manual assertion based on experiment iniRef.13"The nonhelical tail domain of keratin 14 promotes filament bundling and enhances the mechanical properties of keratin intermediate filaments in vitro."_x005F_x005F_x000D_Bousquet O., Ma L., Yamada S., Gu C., Idei T., Takahashi K., Wirtz D., Coulombe P.A._x005F_x005F_x000D_J. Cell Biol. 155:747-754(2001) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH KERATIN FILAMENTS, SUBCELLULAR LOCATION. ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.059 ng/mL |
Human KRT14(Keratin 14) ELISA Kit